RECRUITING

Shaping Tolerance for Delayed Rewards

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Deficits in self-control are of major public health relevance as they contribute to several negative outcomes for both individuals and society. For children, developing self-control is a critically important step toward success in academic settings and social relationships, yet there are few non-pharmacological approaches that have been successful in increasing self-control. We found in our earlier studies that self-control can be increased in preschool-aged children with high impulsivity by using games in which they practice gradually increasing wait-time for larger, more delayed rewards. We are performing this current study to test if this training to increase self-control can be increased using mobile app technology, with computerized game time being used as a reward.

Official Title

Feasibility of Shaping Tolerance for Delayed Rewards in Impulsive 3-6 Year Olds

Quick Facts

Study Start:2017-09-12
Study Completion:2026-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03457402

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:3 Years to 6 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Age 3-6 years
  2. * Hyperactivity/Impulsivity subscale scores of the ADHD Rating Scale-IV Preschool Version (children 3 to 4 years of age) or the Attention and Behavior Scale (children 5 to 6 years of age) ≥ 90th percentile from either the parent or teacher's responses
  3. * Physically and visually able to use the tablet, as determined by pre-assessment performance
  4. * Children taking psychotropic medication will be included, but must maintain the same medication and dose over the course of the study and for each assessment and exhibit elevated levels of impulsivity based on parent or teacher ratings while medicated.
  1. * Children with autism spectrum disorder and/or intellectual disability (by parent or teacher report or the NIH Toolbox Picture Vocabulary Test).

Contacts and Locations

Study Contact

Samantha Blair, PhD
CONTACT
916-703-0325
hs-airlab@ucdavis.edu
Shannon Hoffman, DPT
CONTACT
916-703-0258
hs-airlab@ucdavis.edu

Principal Investigator

Julie Schweitzer, Ph.D.
PRINCIPAL_INVESTIGATOR
UC Davis MIND Institute

Study Locations (Sites)

UC Davis MIND Institute
Sacramento, California, 95817
United States

Collaborators and Investigators

Sponsor: University of California, Davis

  • Julie Schweitzer, Ph.D., PRINCIPAL_INVESTIGATOR, UC Davis MIND Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-09-12
Study Completion Date2026-05

Study Record Updates

Study Start Date2017-09-12
Study Completion Date2026-05

Terms related to this study

Keywords Provided by Researchers

  • delay discounting
  • shaping

Additional Relevant MeSH Terms

  • Impulsivity